Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The granulocyte-macrophage colony-stimulating factor receptor subunit alpha (CSF2RA) is the alpha component of the heterodimeric receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF), a cytokine that regulates the production, differentiation, and function of granulocytes and macrophages. This protein is a member of the cytokine receptor family and is also known as CD116. Upon ligand binding, it heterodimerizes with the beta chain (CD131/CSF2RB) and activates downstream signaling pathways, primarily the JAK/STAT pathway. Mutations or dysfunctions are associated with surfactant metabolism dysfunction type 4 and hereditary pulmonary alveolar proteinosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (CSF2RA).